Concorde Investment Management

Concorde invests in private companies in healthcare, diagnostics, artificial intelligence, biotechnology, and special purpose partnerships.

Concorde’s six-step investment process includes discovery, analysis, strategy, implementation, monitoring, and adaptation.

Concorde offers exclusive private capital investments in private equity, venture partnerships, and sector-specific opportunities.

Concorde’s historical investment holdings span financial technology, consumer products, manufacturing, energy, and healthcare.

Concorde’s team includes Managing Directors Gary B. Wood, Ph.D., John A. Stetter, and Greg B. Wood, along with operations experts Barbie E. Spicer and Marisa A. Parrott.

Concorde Investment Management, an SEC-registered fiduciary based in Dallas, offers personalized investment advice with over 45 years of experience.

Concorde Investment Management, an independent SEC-registered fiduciary based in Dallas, provides personalized wealth advisory services.

Concorde offers direct principal access, mean-reversion strategies, unrestricted investment flexibility, and exclusive private capital opportunities.

Concorde Investment Management handles investment inquiries, client services, and partnership discussions.

Concorde designs bespoke investment solutions tailored to individual client needs.

Concorde Investment Management specializes in wealth management, preservation, and private capital investments in Dallas.

Concorde’s Privacy Policy outlines data collection via forms, cookies, and logs, shared only with trusted providers under confidentiality.

Concorde’s performance disclosure clarifies that financial advisors provide general guidance, not specific tax or legal advice.

Access Concorde’s regulatory compliance documents and SEC filings, including client relationship summaries, annual reports, disclosures, and fund regulatory reports for transparency and compliance purposes.